Nana Balland-Talvard
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients.
Journal: The Journal of clinical investigation
Published: August 04, 2026
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD.
Journal: The Journal of experimental medicine
Published: November 19, 2024
Immune Escape of Acute Myeloid Leukemia after Transplantation.
Journal: Blood cancer discovery
Published: April 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.
Journal: The Journal of clinical investigation
Published: November 08, 2023
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.
Journal: Nature
Published: October 05, 2023
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy.
Journal: Journal for immunotherapy of cancer
Published: September 13, 2021
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.
Journal: Nature communications
Published: April 18, 2020
Expansion of Circulating CD49b+LAG3+ Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host Disease.
Journal: The Journal of investigative dermatology
Published: January 06, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026